We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
R&D_HPAPI Case Study_picture

Case study: Successful process development, validation and commercial manufacturing of an ADC payload


Case Study: Successful process development and manufacturing of an ADC payload from phase 1 to commercial cover


The volume and pace of cancer research continues to accelerate, leading to substantial improvements in patient survival and quality of life.

As a result, the increased demand for anticancer drugs has led to significant growth for highly potent active pharmaceutical ingredients (HPAPIs).

However, HPAPIs present specific manufacturing and handling challenges. A unique know-how and dedicated corporate culture is required to safely manufacture HPAPIs, involving highly-skilled employees working in specialized facilities equipped with high-containment technologies.

Innovators often look to outsource HPAPIs, as CDMOs, such as Novasep, have the capabilities and expertise required. 

This new case study describes the successful process development and manufacturing of an ADC payload from clinical to commercial supply. 

 What you will learn:

> How process robustness and characterization lead to 100% compliant batches 
> The value of the operational excellence program put in place to support commercial needs
> The deliverables obtained


Thank you for your submission ! You can now download your file by clicking on the button below:

Back to resources